chr3:12287368:> Detail (hg38)

Information

Genome

Assembly Position
hg19 chr3:12,328,867-12,475,855 
hg38 chr3:12,287,368-12,434,356

HGVS

Type Transcript Protein
Summary

MGeND

Clinical significance
Variant entry
GWAS entry
Disease area statistics Show details

Frequency

[No Data.]

Prediction

[No Data.]

ClinVar

Clinical Significance
Review star [No Data.]
Show details
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
[No Data.]
DisGeNET
Score Disease name Description Source Pubmed Links
0.004 squamous cell carcinoma NA BeFree,LHGDN Detail
0.080 Cardiomyopathy, Alcoholic NA RGD Detail
<0.001 Cardiomyopathy, Dilated NA BeFree Detail
<0.001 hypertrophic cardiomyopathy NA BeFree Detail
0.021 Cardiovascular Diseases PPARγ genetic variation has been associated with metabolic and cardiovascular di... BeFree,GAD,LHGDN 24841086 Detail
0.003 Carotid Artery Diseases NA LHGDN Detail
0.002 cellulitis NA GAD Detail
<0.001 CNS disorder NA BeFree Detail
<0.001 cerebral infarction NA BeFree Detail
0.002 brain ischemia NA GAD Detail
0.080 Transient ischemic attack NA RGD Detail
0.001 Malignant tumor of cervix The PPARγ is differentially expressed in cervical cancer cells with maximum expr... BeFree 24642720 Detail
0.002 Chest Pain NA GAD Detail
<0.001 bile duct adenoma NA BeFree Detail
0.003 cholangitis NA BeFree,LHGDN Detail
<0.001 Primary biliary cirrhosis NA BeFree Detail
0.003 cholelithiasis NA BeFree,GAD Detail
<0.001 cholestasis NA BeFree Detail
0.003 chondrosarcoma NA BeFree,LHGDN Detail
0.002 chorioamnionitis NA GAD Detail
0.003 choriocarcinoma NA BeFree,LHGDN Detail
0.002 colitis Altogether these data demonstrate that PAK1 overexpression and activation in inf... BeFree 26036343 Detail
0.148 Colonic Neoplasms NA BeFree,CTD_human,GAD,LHGDN Detail
<0.001 Colonic Polyps NA BeFree Detail
0.011 colorectal carcinoma The combination of resveratrol with a PPARγ agonist could be a promising pharmac... BeFree 24975132 Detail
0.011 colorectal carcinoma Luteolin potentiates the sensitivity of colorectal cancer cell lines to oxalipla... BeFree 25075794 Detail
0.140 Colorectal Neoplasms NA BeFree,CTD_human,GAD,LHGDN Detail
<0.001 cystic fibrosis NA BeFree Detail
0.002 Deafness NA GAD Detail
<0.001 Dehydration NA BeFree Detail
<0.001 Presenile dementia NA BeFree Detail
<0.001 Demyelinating Diseases NA BeFree Detail
0.002 Dental Plaque NA GAD Detail
0.002 Mental Depression NA GAD Detail
0.003 Dermatitis, Atopic NA BeFree,LHGDN Detail
0.200 Diabetes Mellitus, Experimental NA CTD_human,RGD Detail
0.013 Diabetes Mellitus, Insulin-Dependent NA BeFree,GAD Detail
0.120 lipoatrophic diabetes mellitus NA BeFree,ORPHANET Detail
0.005 Diabetic Angiopathies NA GAD Detail
0.102 Diabetic Nephropathy NA BeFree,GAD,LHGDN,RGD Detail
0.002 Diabetic Neuropathies NA GAD Detail
0.008 diabetic retinopathy The gene polymorphisms of UCP1 but not PPAR γ and TCF7L2 are associated with dia... BeFree,GAD,LHGDN 25274455 Detail
<0.001 Digestive System Disorders NA BeFree Detail
0.002 Dyspepsia NA GAD Detail
<0.001 Eczema NA BeFree Detail
0.005 Edema NA GAD Detail
<0.001 encephalitis NA BeFree Detail
0.001 Experimental Autoimmune Encephalomyelitis NA BeFree Detail
0.007 Endometrial Neoplasms NA GAD,LHGDN Detail
0.011 endometriosis NA BeFree,GAD,LHGDN Detail
0.006 Esophageal Neoplasms NA BeFree,GAD,LHGDN Detail
<0.001 Exophthalmos NA BeFree Detail
0.094 Fatty Liver NA BeFree,GAD,LHGDN,RGD Detail
0.080 Fetal Growth Retardation NA RGD Detail
0.002 Fetal Membranes, Premature Rupture NA GAD Detail
0.080 Fibrosis NA RGD Detail
0.003 gastritis NA BeFree,GAD Detail
0.002 generalized atherosclerosis NA GAD Detail
0.003 glioblastoma NA BeFree,LHGDN Detail
0.121 Glioma Peroxisome proliferator-activated receptor-γ (PPARγ) agonists have a role of ant... BeFree,CTD_human 26003726 Detail
0.120 glomerulonephritis NA CTD_human Detail
0.003 IgA glomerulonephritis NA BeFree,GAD Detail
<0.001 chronic granulomatous disease NA BeFree Detail
0.003 Graves Disease NA BeFree,GAD Detail
0.002 Growth Disorders NA GAD Detail
0.002 Hearing Loss, Partial NA GAD Detail
0.002 Heart Diseases NA GAD Detail
0.006 Heart failure NA BeFree,GAD,LHGDN Detail
<0.001 congestive heart failure NA BeFree Detail
0.002 hepatitis B MicroRNA-130a can inhibit hepatitis B virus replication via targeting PGC1α and ... BeFree 25595716 Detail
0.002 Hirsutism NA GAD Detail
0.007 HIV Infections NA BeFree,GAD Detail
0.002 Hodgkin Disease NA GAD Detail
<0.001 Hunger NA BeFree Detail
<0.001 Huntington disease NA BeFree Detail
0.003 Hypercholesterolemia NA BeFree,GAD Detail
0.009 hyperglycemia The sEng, sFlt-1, and interleukin-6 were up-regulated, whereas the VEGF and PlGF... BeFree,GAD,LHGDN 24793974 Detail
0.010 hyperinsulinism NA BeFree,GAD,LHGDN Detail
0.007 Hyperlipidemia NA BeFree,GAD,LHGDN Detail
0.009 Hyperlipidemia, Familial Combined NA BeFree,GAD,LHGDN Detail
0.258 Hypertensive disease NA BeFree,CTD_human,GAD,LHGDN,RGD Detail
0.010 pulmonary hypertension NA BeFree,LHGDN Detail
<0.001 hyperthyroidism NA BeFree Detail
0.005 Hypertriglyceridemia NA GAD Detail
<0.001 Immunologic Deficiency Syndromes NA BeFree Detail
0.224 Inflammation NA CTD_human,GAD,LHGDN,RGD Detail
0.006 Inflammatory Bowel Diseases Polymorphisms in the inflammatory pathway genes TLR2, TLR4, TLR9, LY96, NFKBIA, ... BeFree,GAD 24971461 Detail
0.006 Inflammatory Bowel Diseases Modulation of peroxisome proliferator-activated receptor gamma (PPAR γ) by conju... BeFree,GAD 25634802 Detail
<0.001 influenza NA BeFree Detail
0.200 Insulin resistance NA CTD_human,GAD Detail
0.123 ischemia Nitroalkene derivatives of oleic acid (OA-NO2) serve as high-affinity ligand for... BeFree,CTD_human,LHGDN 25766531 Detail
<0.001 Keloid NA BeFree Detail
0.004 Kidney Diseases NA BeFree,GAD Detail
<0.001 Kidney Failure, Acute NA BeFree Detail
0.005 Kidney Failure, Chronic Sequence variants of peroxisome proliferator-activated receptor-gamma gene and t... BeFree,GAD 25784779 Detail
0.003 Kidney Neoplasm NA BeFree,GAD Detail
0.002 Premature Obstetric Labor NA GAD Detail
0.003 Fibroid Tumor NA BeFree,GAD Detail
0.004 leukemia NA BeFree,LHGDN Detail
<0.001 Leukemia, Myelocytic, Acute NA BeFree Detail
0.001 Myeloid Leukemia, Chronic The phenotype and presence of two mutations suggests that biallelic mutations at... BeFree 24980513 Detail
0.001 Myeloid Leukemia, Chronic Erosion of the chronic myeloid leukaemia stem cell pool by PPARγ agonists. BeFree 26331539 Detail
<0.001 acute promyelocytic leukemia NA BeFree Detail
<0.001 Leukoencephalopathy, Progressive Multifocal NA BeFree Detail
<0.001 Lichen planus follicularis NA BeFree Detail
0.002 Lipid Metabolism, Inborn Errors NA GAD Detail
0.120 Lipoidosis NA CTD_human Detail
<0.001 lipoma NA BeFree Detail
0.004 liposarcoma NA BeFree,LHGDN Detail
0.003 liver cirrhosis NA BeFree,GAD Detail
0.003 Biliary cirrhosis NA LHGDN Detail
0.080 Liver Cirrhosis, Experimental NA RGD Detail
0.005 Liver diseases NA BeFree,GAD,LHGDN Detail
0.122 Liver neoplasms Activation of peroxisome proliferator-activated receptor-γ (PPARγ) inhibits hepa... BeFree,CTD_human 25592041 Detail
<0.001 Lung diseases NA BeFree Detail
0.006 Chronic Obstructive Airway Disease NA BeFree,GAD Detail
0.015 Lung Neoplasms NA BeFree,LHGDN Detail
0.083 Lupus Erythematosus, Systemic NA BeFree,GAD,MGD Detail
0.003 lymphoma NA BeFree,LHGDN Detail
0.002 Lymphoma, Non-Hodgkin NA GAD Detail
<0.001 malaria NA BeFree Detail
<0.001 Marfan syndrome NA BeFree Detail
<0.001 medulloblastoma Similarly E2F transcription factors and PPARγ function in both progenitors and m... BeFree 24569090 Detail
0.129 melanoma NA BeFree,CTD_human,GAD,LHGDN Detail
<0.001 premature menopause NA BeFree Detail
<0.001 Mesothelioma NA BeFree Detail
0.126 Metabolic Diseases Peroxisome proliferator-activated receptor gamma (PPAR-γ), a ligand-activated tr... BeFree,CTD_human,LHGDN 25931782 Detail
0.006 multiple myeloma NA BeFree,GAD,LHGDN Detail
0.003 multiple sclerosis In this study, we explored the distribution and role of the mitochondrial antiox... BeFree,GAD 25492529 Detail
<0.001 muscular atrophy NA BeFree Detail
<0.001 myopathy NA BeFree Detail
0.032 myocardial infarction NA BeFree,GAD,LHGDN Detail
0.008 Neoplasm Metastasis NA BeFree,LHGDN Detail
0.120 Nerve Degeneration NA CTD_human Detail
<0.001 nervous system disorder NA BeFree Detail
<0.001 Nesidioblastosis NA BeFree Detail
0.002 neuroblastoma NA BeFree Detail
<0.001 Nevus NA BeFree Detail
<0.001 Melanocytic nevus NA BeFree Detail
0.002 orbit (eye disorders) NA GAD Detail
0.122 Degenerative polyarthritis Association of PPARγ gene polymorphisms with osteoarthritis in a southeast Chine... BeFree,CTD_human 25572230 Detail
0.003 Bone necrosis NA LHGDN Detail
0.008 osteoporosis NA BeFree,GAD Detail
0.002 Osteoporosis, Postmenopausal NA GAD Detail
0.001 osteosarcoma Genistein exerts growth inhibition on human osteosarcoma MG-63 cells via PPARγ p... BeFree 25586304 Detail
0.002 ovarian carcinoma PPARγ inhibits ovarian cancer cells proliferation through upregulation of miR-12... BeFree 25944662 Detail
0.004 Ovarian Diseases NA BeFree Detail
0.080 Pain NA RGD Detail
0.131 Pancreatic Neoplasm NA CTD_human,GAD,LHGDN Detail
0.080 pancreatitis NA BeFree,RGD Detail
<0.001 papilloma NA BeFree Detail
<0.001 Parkinson disease Peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α), a key regu... BeFree 25363075 Detail
0.005 Peptic Ulcer NA BeFree,GAD,LHGDN Detail
0.003 periodontitis NA BeFree,GAD Detail
<0.001 peritonitis NA BeFree Detail
<0.001 pituitary adenoma NA BeFree Detail
<0.001 Pituitary Diseases NA BeFree Detail
0.004 Pituitary Neoplasms NA BeFree,LHGDN Detail
<0.001 placental insufficiency NA BeFree Detail
<0.001 pneumonia NA BeFree Detail
0.062 polycystic ovary syndrome NA BeFree,GAD,LHGDN Detail
<0.001 Adenomatous Polyposis Coli NA BeFree Detail
<0.001 polyps NA BeFree Detail
0.005 pre-eclampsia NA GAD Detail
0.003 Pregnancy Complications NA BeFree,GAD Detail
0.002 Prenatal Exposure Delayed Effects NA GAD Detail
<0.001 prolactinoma NA BeFree Detail
0.011 Prostatic Neoplasms NA BeFree,LHGDN Detail
0.123 psoriasis NA BeFree,CTD_human,LHGDN Detail
0.002 Delayed puberty NA GAD Detail
0.002 Precocious Puberty NA GAD Detail
0.001 pulmonary alveolar proteinosis NA BeFree Detail
<0.001 pulmonary emphysema NA BeFree Detail
0.003 pulmonary fibrosis NA LHGDN Detail
0.005 Rectal Neoplasms NA GAD,LHGDN Detail
<0.001 kidney failure Further mechanistic study is needed to elucidate the role of PPAR-γ among ESRD p... BeFree 25784779 Detail
0.123 Reperfusion Injury NA CTD_human,LHGDN Detail
<0.001 Respiratory Syncytial Virus Infections NA BeFree Detail
<0.001 retinal degeneration NA BeFree Detail
<0.001 retinoblastoma NA BeFree Detail
0.003 Salivary Gland Neoplasms NA BeFree,LHGDN Detail
0.009 sarcoidosis NA BeFree,GAD,LHGDN Detail
<0.001 Sarcoidosis, Pulmonary NA BeFree Detail
0.005 schizophrenia NA BeFree,GAD Detail
0.393 Diabetes Mellitus, Non-Insulin-Dependent We have genotyped three single nucleotide polymorphisms associated with type 2 d... BeFree 14988278 Detail
0.393 Diabetes Mellitus, Non-Insulin-Dependent In contrast, the well-documented associations of peroxisome proliferator-activat... BeFree 15561965 Detail
<0.001 systemic scleroderma A genome-wide association study follow-up suggests a possible role for PPARG in ... BeFree 24401602 Detail
<0.001 systemic scleroderma A candidate gene study reveals association between a variant of the Peroxisome P... BeFree 25986483 Detail
<0.001 Septicemia Activation of the peroxisome proliferator-activated receptor γ counteracts sepsi... BeFree 25559266 Detail
0.003 Dermatologic disorders NA BeFree,GAD Detail
0.002 Starvation NA GAD Detail
0.135 Stomach Neoplasms NA CTD_human,GAD,LHGDN Detail
0.014 Cerebrovascular accident PPARγ was not statistically significantly associated with stroke. BeFree,GAD,LHGDN 25659766 Detail
0.139 Thyroid Neoplasm NA BeFree,CTD_human,LHGDN Detail
<0.001 Thyroid Nodule PAX8/PPARγ rearrangement in thyroid nodules predicts follicular-pattern carcinom... BeFree 24798894 Detail
0.002 Tobacco use disorder NA GAD Detail
<0.001 Chagas disease NA BeFree Detail
<0.001 Attention Deficit Disorder NA BeFree Detail
<0.001 Uterine Fibroids NA BeFree Detail
0.002 Uterine Neoplasms NA GAD Detail
0.003 Vascular Diseases NA BeFree,LHGDN Detail
0.014 Weight Gain NA GAD Detail
<0.001 Werner syndrome NA BeFree Detail
0.007 Helicobacter Infections NA GAD Detail
<0.001 B-Cell Lymphomas NA BeFree Detail
0.120 T-Cell Lymphoma NA CTD_human Detail
0.007 Peripheral Vascular Diseases NA GAD,LHGDN Detail
<0.001 severe combined immunodeficiency NA BeFree Detail
0.007 gestational diabetes NA BeFree,GAD Detail
0.002 Ovarian Failure, Premature NA GAD Detail
0.120 Polycystic Kidney, Autosomal Dominant NA BeFree,CTD_human Detail
0.003 essential hypertension NA BeFree,GAD Detail
<0.001 benign neoplasm NA BeFree Detail
<0.001 Pseudopelade NA BeFree Detail
0.082 Left Ventricular Hypertrophy NA GAD,RGD Detail
<0.001 Thyroid Gland Follicular Adenoma NA BeFree Detail
0.007 Premature Birth NA GAD,LHGDN Detail
0.003 Myocardial Ischemia NA BeFree,GAD Detail
0.001 Adenocarcinoma of lung (disorder) NA BeFree Detail
0.001 esophageal carcinoma NA BeFree Detail
0.001 Idiopathic pulmonary hypertension We showed that miR-27b plays a role endothelial function and NO release and eluc... BeFree 25795136 Detail
<0.001 Malignant neoplasm of brain NA BeFree Detail
<0.001 Secondary malignant neoplasm of bone On follow-up available for 17 patients (mean, 22.4 months), 16 PAX8/PPARγ-positi... BeFree 24798894 Detail
<0.001 Disorder of endocrine ovary NA BeFree Detail
<0.001 proliferative diabetic retinopathy Expression of intraocular peroxisome proliferator-activated receptor gamma in pa... BeFree 25468312 Detail
<0.001 acute myocardial infarction NA BeFree Detail
<0.001 allergic asthma NA BeFree Detail
<0.001 Malnutrition PPARγ links maternal malnutrition and abnormal glucose and lipid metabolism in t... BeFree 25608816 Detail
<0.001 Right Ventricular Hypertrophy NA BeFree Detail
<0.001 Cicatrix, Hypertrophic Peroxisome proliferator-activated receptor-γ (PPAR-γ) agonist inhibits collagen ... BeFree 25704091 Detail
<0.001 Dermatitis, Allergic Contact NA BeFree Detail
<0.001 Aortic Aneurysm, Abdominal NA BeFree Detail
0.002 Tumor Progression NA BeFree Detail
0.002 follicular adenoma NA BeFree Detail
<0.001 Anaplastic carcinoma NA BeFree Detail
<0.001 Undifferentiated carcinoma NA BeFree Detail
<0.001 fatal familial insomnia NA BeFree Detail
0.081 hyperandrogenism NA BeFree,RGD Detail
<0.001 angiomyolipoma NA BeFree Detail
0.007 Follicular thyroid carcinoma Although most tumors carrying this mutation appear to be clinically indolent, at... BeFree 24798894 Detail
0.007 Follicular thyroid carcinoma Low frequency of PAX8-PPARγ rearrangement in follicular thyroid carcinomas in Ja... BeFree 25708358 Detail
0.004 cholangiocarcinoma NA BeFree,LHGDN Detail
<0.001 Carcinoma, Large Cell NA BeFree Detail
0.120 gliosarcoma NA ORPHANET Detail
<0.001 Malignant neoplasm of salivary gland NA BeFree Detail
0.003 Acquired partial lipodystrophy In the last decade, some rare mutations in human PPARγ that might be associated ... BeFree 25004973 Detail
0.003 Acquired partial lipodystrophy To provide a broader context for how these mutations act to generate the clinica... BeFree 25460295 Detail
<0.001 Familial generalized lipodystrophy Biallelic mutations at PPARG cause a congenital, generalized lipodystrophy simil... BeFree 24980513 Detail
<0.001 Systolic hypertension NA BeFree Detail
0.120 pituitary-dependent Cushing's disease NA CTD_human Detail
<0.001 Memory impairment NA BeFree Detail
0.120 Chronobiology Disorders NA CTD_human Detail
0.002 Anaplastic thyroid carcinoma NA BeFree Detail
0.122 Papillary thyroid carcinoma In this series, PAX8/PPARγ rearrangement found in thyroid nodules had a 100% pre... BeFree,ORPHANET 24798894 Detail
0.002 Fibrosis, Liver Histone H3K9 demethylase JMJD1A modulates hepatic stellate cells activation and ... BeFree 25609425 Detail
<0.001 Interstitial fibrosis Morphological and haemodynamic measurements showed that the activation of PPARγ ... BeFree 25633415 Detail
<0.001 Iron deficiency NA BeFree Detail
0.002 coronary stenosis NA GAD Detail
0.018 Malignant neoplasm of lung NA BeFree,GAD Detail
0.200 Acute Lung Injury NA CTD_human,RGD Detail
0.002 Ventricular Dysfunction, Left NA GAD Detail
<0.001 Sepsis Activation of the peroxisome proliferator-activated receptor γ counteracts sepsi... BeFree 25559266 Detail
<0.001 chronic cholangitis NA BeFree Detail
<0.001 Cholestasis of pregnancy NA BeFree Detail
0.012 Impaired glucose tolerance NA BeFree,GAD,LHGDN Detail
<0.001 Infectious colitis NA BeFree Detail
<0.001 gastric adenocarcinoma NA BeFree Detail
<0.001 Liver and Intrahepatic Biliary Tract Carcinoma Taken together, these results provide new evidence for the action mechanisms of ... BeFree 25592041 Detail
<0.001 Adenocarcinoma Of Esophagus NA BeFree Detail
<0.001 Conventional (Clear Cell) Renal Cell Carcinoma NA BeFree Detail
<0.001 Solid tumour NA BeFree Detail
0.120 leukostasis NA BeFree,CTD_human Detail
<0.001 Vascular Neoplasms NA BeFree Detail
0.001 cervix carcinoma The PPARγ is differentially expressed in cervical cancer cells with maximum expr... BeFree 24642720 Detail
<0.001 Obesity, Abdominal NA BeFree Detail
0.003 Restenosis NA BeFree,GAD Detail
<0.001 Senile Plaques NA BeFree Detail
0.120 giant cell glioblastoma NA ORPHANET Detail
<0.001 Adenocarcinoma of colon NA BeFree Detail
<0.001 Impaired cognition NA BeFree Detail
0.003 Thyroid associated opthalmopathies Moreover, dasatinib reduced PPAR-γ mRNA expression in cultured GO orbital tissue... BeFree,GAD 26284551 Detail
<0.001 Proliferative retinopathy NA BeFree Detail
<0.001 Anterior myocardial infarction NA BeFree Detail
0.005 Complications of Diabetes Mellitus NA GAD Detail
<0.001 Congenital aneurysm of ascending aorta NA BeFree Detail
<0.001 Malignant neoplasm of liver Taken together, these results provide new evidence for the action mechanisms of ... BeFree 25592041 Detail
0.003 Arrhythmogenic Right Ventricular Dysplasia NA BeFree,GAD Detail
0.003 prediabetes syndrome NA BeFree,GAD Detail
<0.001 Helicobacter pylori (H. pylori) infection in conditions classified elsewhere and of unspecified site NA BeFree Detail
<0.001 Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site NA BeFree Detail
0.014 Malignant neoplasm of prostate We found that in vitro culture of PC-3 cells with lutein induced mild decrease i... BeFree,GAD 25162762 Detail
0.014 Malignant neoplasm of prostate EPI-001 is a selective peroxisome proliferator-activated receptor-gamma modulato... BeFree,GAD 25669987 Detail
0.014 Malignant neoplasm of prostate Further studies are needed to assess the functional role of PPAR-γ and to valida... BeFree,GAD 25931782 Detail
<0.001 Hematopoietic Neoplasms NA BeFree Detail
0.080 Endotoxemia NA RGD Detail
<0.001 Pulmonary Cystic Fibrosis NA BeFree Detail
0.002 thrombophilia NA GAD Detail
0.003 Non-alcoholic Fatty Liver Disease NA BeFree Detail
<0.001 Chronic Kidney Insufficiency NA BeFree Detail
<0.001 Chronic small plaque psoriasis NA BeFree Detail
0.003 Osteoarthritis, Knee NA BeFree,GAD Detail
0.001 Follicular neoplasm NA BeFree Detail
<0.001 endometrial carcinoma This crosstalk may facilitate the development of novel therapeutic methods targe... BeFree 25592200 Detail
<0.001 Secondary malignant neoplasm of liver NA BeFree Detail
0.005 dementia NA BeFree,GAD Detail
0.002 body mass NA GAD Detail
0.001 Neurodegenerative Disorders NA BeFree Detail
<0.001 Hepatitis B, Chronic NA BeFree Detail
<0.001 Myxoid/Round Cell Liposarcoma NA BeFree Detail
0.005 Malignant neoplasm of esophagus NA BeFree,GAD Detail
0.006 Thyroid carcinoma The posttest probability of thyroid cancer was 100% for nodules positive for BRA... BeFree 24811481 Detail
0.006 Thyroid carcinoma We reviewed a consecutive series of 1510 patients who had initial thyroidectomy ... BeFree 26258321 Detail
0.003 Carotid Atherosclerosis NA BeFree,GAD Detail
0.001 Osteosarcoma of bone Genistein exerts growth inhibition on human osteosarcoma MG-63 cells via PPARγ p... BeFree 25586304 Detail
<0.001 Aqueous Humor Disorders The PPARγ concentrations in the aqueous humor and vitreous fluid were significan... BeFree 25468312 Detail
0.015 Carcinogenesis Taken together, these results provide new evidence for the action mechanisms of ... BeFree 25592041 Detail
0.015 Carcinogenesis These findings will extend our understanding of the function of PPARγ in tumorig... BeFree 25944662 Detail
<0.001 monocytic leukemia NA BeFree Detail
0.010 prostate carcinoma We found that in vitro culture of PC-3 cells with lutein induced mild decrease i... BeFree 25162762 Detail
0.010 prostate carcinoma EPI-001 is a selective peroxisome proliferator-activated receptor-gamma modulato... BeFree 25669987 Detail
0.010 prostate carcinoma Further studies are needed to assess the functional role of PPAR-γ and to valida... BeFree 25931782 Detail
0.002 hepatopulmonary syndrome NA GAD Detail
0.003 Epithelial ovarian cancer NA BeFree,GAD Detail
0.015 breast carcinoma PPARγ-inactive Δ2-troglitazone independently triggers ER stress and apoptosis in... BeFree 24293218 Detail
0.015 breast carcinoma Collectively, our observations suggest potential applications for PTER-ITC in br... BeFree 25119466 Detail
0.015 breast carcinoma Lack of effects of peroxisome proliferator-activated receptor gamma genetic poly... BeFree 25422184 Detail
0.015 breast carcinoma We conclude that the interaction between IGFBP-3 and PPARγ is important for the ... BeFree 25449421 Detail
0.015 breast carcinoma Our findings suggest that omega-3 DHADA- and EPADA activation of PPARγ may assum... BeFree 26272430 Detail
0.004 Carcinoma of lung NA BeFree Detail
<0.001 Malignant neoplasm of gastrointestinal tract NA BeFree Detail
<0.001 Secondary malignant neoplasm of lymph node NA BeFree Detail
0.134 colon carcinoma A role for peroxisome proliferator-activated receptor gamma in resveratrol-induc... BeFree,CLINVAR 24975132 Detail
0.134 colon carcinoma In the last decade, some rare mutations in human PPARγ that might be associated ... BeFree,CLINVAR 25004973 Detail
0.134 colon carcinoma The mycotoxin patulin decreases expression of density-enhanced phosphatase-1 by ... BeFree,CLINVAR 25098256 Detail
0.002 Carcinoma of bladder NA BeFree Detail
0.002 Central neuroblastoma NA BeFree Detail
<0.001 Atrophy, Muscular, Spinobulbar Treatment with pioglitazone (PG), an activator of PPARγ, improved the viability ... BeFree 25168383 Detail
0.002 Pregnancy associated hypertension NA GAD Detail
<0.001 Pseudomonas aeruginosa infection NA BeFree Detail
<0.001 Endothelial dysfunction NA BeFree Detail
0.120 Drug-Induced Liver Injury NA GWASCAT Detail
<0.001 Carcinoma, Pancreatic Ductal NA BeFree Detail
<0.001 Cerebral Ischemia NA BeFree Detail
0.004 ovarian neoplasm NA BeFree,LHGDN Detail
0.002 Microsatellite Instability NA GAD Detail
0.002 Insulin Sensitivity NA GAD Detail
0.003 cholecystolithiasis NA BeFree,GAD Detail
<0.001 Vascular inflammations NA BeFree Detail
0.001 Ischemic stroke These results indicate that the C161T of PPARγ may reduce the risk of IS by modu... BeFree 24841086 Detail
0.001 Ischemic stroke PPARγ and IL-6 - 174G>C gene variants in Croatian patients with ischemic stroke. BeFree 25659766 Detail
0.011 Acute coronary syndrome NA BeFree,GAD,LHGDN Detail
0.002 coronary restenosis NA GAD Detail
<0.001 Polyp of large intestine NA BeFree Detail
<0.001 Thyroid hyperplasia NA BeFree Detail
0.003 HIV-Associated Lipodystrophy Syndrome NA BeFree,GAD Detail
0.002 Malignant neoplasm of ovary PPARγ inhibits ovarian cancer cells proliferation through upregulation of miR-12... BeFree 25944662 Detail
0.002 Glucose Metabolism Disorders NA GAD Detail
<0.001 Chronic metabolic disorder NA BeFree Detail
<0.001 attention deficit hyperactivity disorder NA BeFree Detail
0.002 Systemic arterial pressure NA GAD Detail
<0.001 extraskeletal myxoid chondrosarcoma NA BeFree Detail
<0.001 Precursor B-cell lymphoblastic leukemia NA BeFree Detail
<0.001 Adenoma of large intestine NA BeFree Detail
<0.001 ACTH-secreting pituitary adenoma NA BeFree Detail
<0.001 Liver regeneration disorder NA BeFree Detail
<0.001 M5b Acute differentiated monocytic leukemia NA BeFree Detail
<0.001 pancreatic ductal adenocarcinoma NA BeFree Detail
0.001 differentiated thyroid gland carcinoma In this series, PAX8/PPARγ rearrangement found in thyroid nodules had a 100% pre... BeFree 24798894 Detail
<0.001 Epithelioma NA BeFree Detail
<0.001 Granulosa cell tumor of the ovary NA BeFree Detail
0.002 hearing impairment NA GAD Detail
<0.001 Vascular lesions NA BeFree Detail
<0.001 Benign melanocytic nevus NA BeFree Detail
0.022 Mammary Neoplasms We conclude that the interaction between IGFBP-3 and PPARγ is important for the ... BeFree,LHGDN 25449421 Detail
<0.001 Hepatocarcinogenesis NA BeFree Detail
<0.001 Mammary Tumorigenesis NA BeFree Detail
<0.001 Cancer Cell Growth NA BeFree Detail
<0.001 Skin Carcinogenesis NA BeFree Detail
0.005 Hypertriglyceridemia result NA GAD Detail
0.039 colorectal cancer The combination of resveratrol with a PPARγ agonist could be a promising pharmac... BeFree,GAD 24975132 Detail
0.039 colorectal cancer Luteolin potentiates the sensitivity of colorectal cancer cell lines to oxalipla... BeFree,GAD 25075794 Detail
0.001 Chronic Kidney Diseases NA BeFree Detail
<0.001 Glioblastoma multiforme NA BeFree Detail
<0.001 androgen independent prostate cancer NA BeFree Detail
<0.001 Benign Prostatic Hyperplasia NA BeFree Detail
<0.001 Non-Neoplastic Disorder NA BeFree Detail
<0.001 Familial Partial Lipodystrophy, Type 2 NA BeFree Detail
0.080 congenital generalized lipodystrophy type 2 NA MGD Detail
0.120 Carotid intimal medial thickness 1 NA CTD_human Detail
<0.001 Bulbo-Spinal Atrophy, X-Linked Treatment with pioglitazone (PG), an activator of PPARγ, improved the viability ... BeFree 25168383 Detail
<0.001 Mammographic Density NA BeFree Detail
<0.001 Craniometaphyseal dysplasia, autosomal dominant NA BeFree Detail
<0.001 Pyruvate dehydrogenase E3-binding protein deficiency NA BeFree Detail
0.002 Venous thromboembolism NA GAD Detail
0.002 Mixed hyperlipidemia (disorder) NA GAD Detail
0.125 liver carcinoma MicroRNA-130b promotes cell aggressiveness by inhibiting peroxisome proliferator... BeFree,CTD_human 25387077 Detail
0.125 liver carcinoma Activation of peroxisome proliferator-activated receptor-γ (PPARγ) inhibits hepa... BeFree,CTD_human 25592041 Detail
0.125 liver carcinoma MiR-27a promotes hepatocellular carcinoma cell proliferation through suppression... BeFree,CTD_human 25836616 Detail
<0.001 Chronic kidney disease stage 5 Sequence variants of peroxisome proliferator-activated receptor-gamma gene and t... BeFree 25784779 Detail
<0.001 Childhood myelodysplastic syndrome NA BeFree Detail
<0.001 Idiopathic Interstitial Pneumonias NA BeFree Detail
<0.001 Pediatric Obesity NA BeFree Detail
<0.001 Allergic rhinitis (disorder) NA BeFree Detail
0.200 Acute kidney injury NA CTD_human,RGD Detail
<0.001 Hypoadiponectinemia NA BeFree Detail
0.001 Steatohepatitis NA BeFree Detail
<0.001 Promyelocytic leukemia NA BeFree Detail
0.017 Weight Loss Adverse Event NA GAD Detail
0.014 Weight Gain Adverse Event NA GAD Detail
0.002 Infection of amniotic sac and membranes, unspecified, unspecified trimester, not applicable or unspecified NA GAD Detail
0.005 Chronic ulcerative colitis NA GAD Detail
0.120 Thyroid cancer, follicular NA CTD_human Detail
<0.001 Gestational trophoblastic disease NA BeFree Detail
<0.001 Plaque, Amyloid NA BeFree Detail
<0.001 Scarring alopecia NA BeFree Detail
0.001 Pulmonary arterial hypertension We showed that miR-27b plays a role endothelial function and NO release and eluc... BeFree 25795136 Detail
0.080 Idiopathic pulmonary arterial hypertension NA MGD Detail
0.001 Ischemic Cerebrovascular Accident These results indicate that the C161T of PPARγ may reduce the risk of IS by modu... BeFree 24841086 Detail
0.001 Ischemic Cerebrovascular Accident PPARγ and IL-6 - 174G>C gene variants in Croatian patients with ischemic stroke. BeFree 25659766 Detail
0.002 granulomatosis with polyangiitis NA GAD Detail
<0.001 Triple Negative Breast Neoplasms NA BeFree Detail
<0.001 Neutrophilia (disorder) NA BeFree Detail
<0.001 Melanocytic nevus of skin NA BeFree Detail
0.003 Infection NA LHGDN Detail
<0.001 Insulin resistance syndrome NA BeFree Detail
0.001 Pulmonary hypertension, primary, 1, with hereditary hemorrhagic telangiectasia We showed that miR-27b plays a role endothelial function and NO release and eluc... BeFree 25795136 Detail
0.002 Hearing Loss NA GAD Detail
<0.001 Congenital Abnormality NA BeFree Detail
<0.001 acanthosis nigricans NA BeFree Detail
0.001 acromegaly NA BeFree Detail
0.138 adenocarcinoma NA BeFree,CTD_human,GAD,LHGDN Detail
0.013 adenoma NA BeFree,GAD,LHGDN Detail
<0.001 Tumors of Adrenal Cortex NA BeFree Detail
0.002 Albuminuria NA GAD Detail
0.002 Alcoholic Intoxication, Chronic NA GAD Detail
0.004 amyotrophic lateral sclerosis Taken together, our data provide evidence that modulating PPARγ activity, althou... BeFree,GAD 25432537 Detail
<0.001 Anaplasia NA BeFree Detail
<0.001 aplastic anemia NA BeFree Detail
0.002 Angina Pectoris, Variant NA GAD Detail
<0.001 aortic aneurysm NA BeFree Detail
<0.001 arthritis NA BeFree Detail
0.003 Arthritis, Psoriatic NA BeFree,GAD Detail
0.006 rheumatoid arthritis NA BeFree,GAD Detail
0.008 asthma NA BeFree,GAD,LHGDN Detail
<0.001 Ataxia NA BeFree Detail
<0.001 Autoimmune Diseases NA BeFree Detail
0.120 Barrett esophagus NA CTD_human Detail
0.002 Biliary Tract Neoplasm NA GAD Detail
0.007 Malignant neoplasm of urinary bladder NA BeFree,GAD Detail
0.088 Bladder Neoplasm NA BeFree,LHGDN,RGD Detail
<0.001 borderline personality disorder NA BeFree Detail
<0.001 Brain Neoplasms NA BeFree Detail
0.023 Malignant neoplasm of breast PPARγ-inactive Δ2-troglitazone independently triggers ER stress and apoptosis in... BeFree,GAD 24293218 Detail
0.023 Malignant neoplasm of breast Collectively, our observations suggest potential applications for PTER-ITC in br... BeFree,GAD 25119466 Detail
0.023 Malignant neoplasm of breast Lack of effects of peroxisome proliferator-activated receptor gamma genetic poly... BeFree,GAD 25422184 Detail
0.023 Malignant neoplasm of breast We conclude that the interaction between IGFBP-3 and PPARγ is important for the ... BeFree,GAD 25449421 Detail
0.023 Malignant neoplasm of breast Our findings suggest that omega-3 DHADA- and EPADA activation of PPARγ may assum... BeFree,GAD 26272430 Detail
<0.001 bronchopulmonary dysplasia NA BeFree Detail
0.002 calcinosis NA GAD Detail
0.013 Malignant tumor of colon A role for peroxisome proliferator-activated receptor gamma in resveratrol-induc... BeFree 24975132 Detail
0.013 Malignant tumor of colon In the last decade, some rare mutations in human PPARγ that might be associated ... BeFree 25004973 Detail
0.013 Malignant tumor of colon The mycotoxin patulin decreases expression of density-enhanced phosphatase-1 by ... BeFree 25098256 Detail
<0.001 Adenocarcinoma of prostate Expression of Peroxisome Proliferator Activated Receptor gamma in Prostatic Aden... BeFree 25931782 Detail
0.001 Rectal Carcinoma NA BeFree Detail
0.004 Malignant neoplasm of thyroid The posttest probability of thyroid cancer was 100% for nodules positive for BRA... BeFree 24811481 Detail
0.004 Malignant neoplasm of thyroid We reviewed a consecutive series of 1510 patients who had initial thyroidectomy ... BeFree 26258321 Detail
0.007 Non-small cell lung carcinoma NA BeFree,LHGDN Detail
0.001 Carcinoma, Papillary NA BeFree Detail
0.003 renal cell carcinoma NA BeFree,GAD Detail
Annotation

Annotations

DescrptionSourceLinks
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
PPARγ genetic variation has been associated with metabolic and cardiovascular diseases. DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
The PPARγ is differentially expressed in cervical cancer cells with maximum expression in ME180 cell... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
Altogether these data demonstrate that PAK1 overexpression and activation in inflammation and coliti... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
The combination of resveratrol with a PPARγ agonist could be a promising pharmacological approach fo... DisGeNET Detail
Luteolin potentiates the sensitivity of colorectal cancer cell lines to oxaliplatin through the PPAR... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
The gene polymorphisms of UCP1 but not PPAR γ and TCF7L2 are associated with diabetic retinopathy in... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
Peroxisome proliferator-activated receptor-γ (PPARγ) agonists have a role of antineoplastic in vario... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
MicroRNA-130a can inhibit hepatitis B virus replication via targeting PGC1α and PPARγ. DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
The sEng, sFlt-1, and interleukin-6 were up-regulated, whereas the VEGF and PlGF were down-regulated... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
Polymorphisms in the inflammatory pathway genes TLR2, TLR4, TLR9, LY96, NFKBIA, NFKB1, TNFA, TNFRSF1... DisGeNET Detail
Modulation of peroxisome proliferator-activated receptor gamma (PPAR γ) by conjugated fatty acid in ... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
Nitroalkene derivatives of oleic acid (OA-NO2) serve as high-affinity ligand for PPAR-γ, which regul... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
Sequence variants of peroxisome proliferator-activated receptor-gamma gene and the clinical courses ... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
The phenotype and presence of two mutations suggests that biallelic mutations at PPARG cause a CGL s... DisGeNET Detail
Erosion of the chronic myeloid leukaemia stem cell pool by PPARγ agonists. DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
Activation of peroxisome proliferator-activated receptor-γ (PPARγ) inhibits hepatoma cell growth via... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
Similarly E2F transcription factors and PPARγ function in both progenitors and medulloblastoma to op... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
Peroxisome proliferator-activated receptor gamma (PPAR-γ), a ligand-activated transcription factor h... DisGeNET Detail
NA DisGeNET Detail
In this study, we explored the distribution and role of the mitochondrial antioxidants peroxiredoxin... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
Association of PPARγ gene polymorphisms with osteoarthritis in a southeast Chinese population. DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
Genistein exerts growth inhibition on human osteosarcoma MG-63 cells via PPARγ pathway. DisGeNET Detail
PPARγ inhibits ovarian cancer cells proliferation through upregulation of miR-125b. DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
Peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α), a key regulator of mitochondri... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
Further mechanistic study is needed to elucidate the role of PPAR-γ among ESRD patients. DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
We have genotyped three single nucleotide polymorphisms associated with type 2 diabetes in a large t... DisGeNET Detail
In contrast, the well-documented associations of peroxisome proliferator-activated receptor gamma P1... DisGeNET Detail
A genome-wide association study follow-up suggests a possible role for PPARG in systemic sclerosis s... DisGeNET Detail
A candidate gene study reveals association between a variant of the Peroxisome Proliferator-Activate... DisGeNET Detail
Activation of the peroxisome proliferator-activated receptor γ counteracts sepsis-induced T cell cyt... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
PPARγ was not statistically significantly associated with stroke. DisGeNET Detail
NA DisGeNET Detail
PAX8/PPARγ rearrangement in thyroid nodules predicts follicular-pattern carcinomas, in particular th... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
We showed that miR-27b plays a role endothelial function and NO release and elucidated a potential m... DisGeNET Detail
NA DisGeNET Detail
On follow-up available for 17 patients (mean, 22.4 months), 16 PAX8/PPARγ-positive cancers showed no... DisGeNET Detail
NA DisGeNET Detail
Expression of intraocular peroxisome proliferator-activated receptor gamma in patients with prolifer... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
PPARγ links maternal malnutrition and abnormal glucose and lipid metabolism in the offspring of mice... DisGeNET Detail
NA DisGeNET Detail
Peroxisome proliferator-activated receptor-γ (PPAR-γ) agonist inhibits collagen synthesis in human h... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
Although most tumors carrying this mutation appear to be clinically indolent, at least on short-term... DisGeNET Detail
Low frequency of PAX8-PPARγ rearrangement in follicular thyroid carcinomas in Japanese patients. DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
In the last decade, some rare mutations in human PPARγ that might be associated with partial lipodys... DisGeNET Detail
To provide a broader context for how these mutations act to generate the clinical features of partia... DisGeNET Detail
Biallelic mutations at PPARG cause a congenital, generalized lipodystrophy similar to the Berardinel... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
In this series, PAX8/PPARγ rearrangement found in thyroid nodules had a 100% predictive value for di... DisGeNET Detail
Histone H3K9 demethylase JMJD1A modulates hepatic stellate cells activation and liver fibrosis by ep... DisGeNET Detail
Morphological and haemodynamic measurements showed that the activation of PPARγ improved the impaire... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
Activation of the peroxisome proliferator-activated receptor γ counteracts sepsis-induced T cell cyt... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
Taken together, these results provide new evidence for the action mechanisms of PPARγ in carcinogene... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
The PPARγ is differentially expressed in cervical cancer cells with maximum expression in ME180 cell... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
Moreover, dasatinib reduced PPAR-γ mRNA expression in cultured GO orbital tissue. DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
Taken together, these results provide new evidence for the action mechanisms of PPARγ in carcinogene... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
We found that in vitro culture of PC-3 cells with lutein induced mild decrease in proliferation that... DisGeNET Detail
EPI-001 is a selective peroxisome proliferator-activated receptor-gamma modulator with inhibitory ef... DisGeNET Detail
Further studies are needed to assess the functional role of PPAR-γ and to validate its therapeutic i... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
This crosstalk may facilitate the development of novel therapeutic methods targeting PPARγ in endome... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
The posttest probability of thyroid cancer was 100% for nodules positive for BRAF or RET-PTC, 70% fo... DisGeNET Detail
We reviewed a consecutive series of 1510 patients who had initial thyroidectomy for TC with routine ... DisGeNET Detail
NA DisGeNET Detail
Genistein exerts growth inhibition on human osteosarcoma MG-63 cells via PPARγ pathway. DisGeNET Detail
The PPARγ concentrations in the aqueous humor and vitreous fluid were significantly higher in PDR pa... DisGeNET Detail
Taken together, these results provide new evidence for the action mechanisms of PPARγ in carcinogene... DisGeNET Detail
These findings will extend our understanding of the function of PPARγ in tumorigenesis and miR-125b ... DisGeNET Detail
NA DisGeNET Detail
We found that in vitro culture of PC-3 cells with lutein induced mild decrease in proliferation that... DisGeNET Detail
EPI-001 is a selective peroxisome proliferator-activated receptor-gamma modulator with inhibitory ef... DisGeNET Detail
Further studies are needed to assess the functional role of PPAR-γ and to validate its therapeutic i... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
PPARγ-inactive Δ2-troglitazone independently triggers ER stress and apoptosis in breast cancer cells... DisGeNET Detail
Collectively, our observations suggest potential applications for PTER-ITC in breast cancer preventi... DisGeNET Detail
Lack of effects of peroxisome proliferator-activated receptor gamma genetic polymorphisms on breast ... DisGeNET Detail
We conclude that the interaction between IGFBP-3 and PPARγ is important for the growth-inhibitory ef... DisGeNET Detail
Our findings suggest that omega-3 DHADA- and EPADA activation of PPARγ may assume biological relevan... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
A role for peroxisome proliferator-activated receptor gamma in resveratrol-induced colon cancer cell... DisGeNET Detail
In the last decade, some rare mutations in human PPARγ that might be associated with partial lipodys... DisGeNET Detail
The mycotoxin patulin decreases expression of density-enhanced phosphatase-1 by down-regulating PPAR... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
Treatment with pioglitazone (PG), an activator of PPARγ, improved the viability of the cellular mode... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
These results indicate that the C161T of PPARγ may reduce the risk of IS by modulation of adipose me... DisGeNET Detail
PPARγ and IL-6 - 174G>C gene variants in Croatian patients with ischemic stroke. DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
PPARγ inhibits ovarian cancer cells proliferation through upregulation of miR-125b. DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
In this series, PAX8/PPARγ rearrangement found in thyroid nodules had a 100% predictive value for di... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
We conclude that the interaction between IGFBP-3 and PPARγ is important for the growth-inhibitory ef... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
The combination of resveratrol with a PPARγ agonist could be a promising pharmacological approach fo... DisGeNET Detail
Luteolin potentiates the sensitivity of colorectal cancer cell lines to oxaliplatin through the PPAR... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
Treatment with pioglitazone (PG), an activator of PPARγ, improved the viability of the cellular mode... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
MicroRNA-130b promotes cell aggressiveness by inhibiting peroxisome proliferator-activated receptor ... DisGeNET Detail
Activation of peroxisome proliferator-activated receptor-γ (PPARγ) inhibits hepatoma cell growth via... DisGeNET Detail
MiR-27a promotes hepatocellular carcinoma cell proliferation through suppression of its target gene ... DisGeNET Detail
Sequence variants of peroxisome proliferator-activated receptor-gamma gene and the clinical courses ... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
We showed that miR-27b plays a role endothelial function and NO release and elucidated a potential m... DisGeNET Detail
NA DisGeNET Detail
These results indicate that the C161T of PPARγ may reduce the risk of IS by modulation of adipose me... DisGeNET Detail
PPARγ and IL-6 - 174G>C gene variants in Croatian patients with ischemic stroke. DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
We showed that miR-27b plays a role endothelial function and NO release and elucidated a potential m... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
Taken together, our data provide evidence that modulating PPARγ activity, although not effective at ... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
PPARγ-inactive Δ2-troglitazone independently triggers ER stress and apoptosis in breast cancer cells... DisGeNET Detail
Collectively, our observations suggest potential applications for PTER-ITC in breast cancer preventi... DisGeNET Detail
Lack of effects of peroxisome proliferator-activated receptor gamma genetic polymorphisms on breast ... DisGeNET Detail
We conclude that the interaction between IGFBP-3 and PPARγ is important for the growth-inhibitory ef... DisGeNET Detail
Our findings suggest that omega-3 DHADA- and EPADA activation of PPARγ may assume biological relevan... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
A role for peroxisome proliferator-activated receptor gamma in resveratrol-induced colon cancer cell... DisGeNET Detail
In the last decade, some rare mutations in human PPARγ that might be associated with partial lipodys... DisGeNET Detail
The mycotoxin patulin decreases expression of density-enhanced phosphatase-1 by down-regulating PPAR... DisGeNET Detail
Expression of Peroxisome Proliferator Activated Receptor gamma in Prostatic Adenocarcinoma. DisGeNET Detail
NA DisGeNET Detail
The posttest probability of thyroid cancer was 100% for nodules positive for BRAF or RET-PTC, 70% fo... DisGeNET Detail
We reviewed a consecutive series of 1510 patients who had initial thyroidectomy for TC with routine ... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail

Overlapped Transcript Coordinates

Gene Transcript ID Exon Number Chromosome Start Stop Type Amino Mutation Transcript Position Links

Overlapped Transcript

Gene Transcript ID Chromosome Start Stop Links
Gene
-
dbSNP
rs386597997 dbSNP
Genome
hg38
Position
chr3:12,287,368-12,434,356
Variant Type
snv
Genome browser